These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10371225)

  • 61. [Diastolic heart failure. Treatment].
    Cohen Solal A; Salengro E; Garçon P; Logeart D
    Presse Med; 2000 Nov; 29(34):1894-6. PubMed ID: 11709824
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heart failure.
    McKelvie R
    Clin Evid; 2004 Jun; (11):122-48. PubMed ID: 15652002
    [No Abstract]   [Full Text] [Related]  

  • 63. [Chronic left heart ventricle failure and inotropic stimulation].
    Myhre ES; Gundersen T; Dickstein K; Hole T; Kjekshus J; Rønnevik P; Smith P; Westheim A
    Tidsskr Nor Laegeforen; 1995 Jan; 115(3):360-4. PubMed ID: 7855836
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of vasodilator and inotropic drugs on clinical symptoms and long-term survival in chronic congestive heart failure.
    Packer M
    Eur Heart J; 1988 Jun; 9 Suppl H():105-8. PubMed ID: 2901957
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New treatment strategies in patients with impaired left ventricular systolic function. Part II: Treatment of moderate to severe cardiac dysfunction.
    Rozo JC; Barry WL; Stouffer GA
    Am J Med Sci; 1999 May; 317(5):312-7. PubMed ID: 10334119
    [No Abstract]   [Full Text] [Related]  

  • 67. [Programs for continuing medical education: B session; 1. The pathophysiology of heart failure--is it the disease of the heart?].
    Kitakaze M
    Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):681-6. PubMed ID: 24796136
    [No Abstract]   [Full Text] [Related]  

  • 68. [Arterial hypertension and cardiac decompensation].
    Degaute JP
    Rev Med Brux; 1996 Sep; 17(4):272-4. PubMed ID: 8927860
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Update on therapy for heart failure.
    DiBianco R
    Am J Med; 2003 Oct; 115(6):480-8. PubMed ID: 14563505
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Medical treatment of chronic heart failure].
    Schüpfer CA
    Praxis (Bern 1994); 2007 Mar; 96(11):405-10. PubMed ID: 17405532
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives.
    Ammirati E; Contri R; Coppini R; Cecchi F; Frigerio M; Olivotto I
    Eur J Heart Fail; 2016 Sep; 18(9):1106-18. PubMed ID: 27109894
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.
    Mallick A; Gandhi PU; Gaggin HK; Ibrahim N; Januzzi JL
    JACC Heart Fail; 2016 Sep; 4(9):749-55. PubMed ID: 27179830
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recommended Heart Failure Medications and Adverse Drug Reactions in Women.
    Bots SH; den Ruijter HM
    Circulation; 2019 Mar; 139(12):1469-1471. PubMed ID: 30883224
    [No Abstract]   [Full Text] [Related]  

  • 74. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
    Naegele M; Flammer AJ; Enseleit F; Ruschitzka F
    Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of losartan and captopril in ELITE II.
    Meyer FP
    Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022947
    [No Abstract]   [Full Text] [Related]  

  • 78. Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction.
    McMurray JJ
    Heart; 2001 Jul; 86(1):97-103. PubMed ID: 11410575
    [No Abstract]   [Full Text] [Related]  

  • 79. Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study.
    Pitt B; Latini R; Maggioni AP; Solomon SD; Smith BA; Wright M; Prescott MF; McMurray JJ
    Eur J Heart Fail; 2011 Jul; 13(7):755-64. PubMed ID: 21467028
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impacts of person-centred integrated chronic heart failure and palliative home care on pharmacological heart failure treatment: a substudy of a randomised trial.
    Markgren R; Brännström M; Lundgren C; Boman K
    BMJ Support Palliat Care; 2019 Mar; 9(1):e10. PubMed ID: 26792391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.